Nuzenio

Kalkine Mayne Pharma

Kalkine Mayne Pharma news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 12 latest news signals 2 publisher sources 100/100 entity strength

Latest news

Inside Mayne Pharma’s (ASX:MYX) Latest Price Move and What Healthcare Investors Are Watching - KalkineKalkine · Fri, 07 Aug 2026 08:05:00 GMT Why Are Investors Watching BLS Pharmaceuticals (ASX:BLS) Shares After Its Latest Price Move - KalkineKalkine · Fri, 07 Aug 2026 08:05:00 GMT Mayne Pharma (ASX:MYX) Faces Board Pressure as Investors Push for Strategic Reset After Takeover Collapse - KalkineKalkine · Thu, 06 Aug 2026 02:36:00 GMT Mayne Pharma Group Announces Expiry of 24,860 Performance Rights Effective July 30, 2026 - Kalkine MediaKalkine Media · Wed, 05 Aug 2026 07:16:57 GMT Mayne Pharma Group Issues 161,465 Ordinary Shares Following Performance Rights Conversion - KalkineKalkine · Wed, 05 Aug 2026 07:16:57 GMT Mayne Pharma Group Reports Lapse of 24,860 Performance Rights - KalkineKalkine · Wed, 05 Aug 2026 07:16:57 GMT Which ASX Penny Stocks Could Be Emerging Growth Stories? - Kalkine MediaKalkine Media · Wed, 05 Aug 2026 00:27:00 GMT Mayne Pharma Surges More Than 10% as Investors Pile Back In - KalkineKalkine · Tue, 04 Aug 2026 04:58:00 GMT

Timeline

Fri, 07 Aug 2026 08:05:00 GMTInside Mayne Pharma’s (ASX:MYX) Latest Price Move and What Healthcare Investors Are Watching - Kalkine

Fri, 07 Aug 2026 08:05:00 GMTWhy Are Investors Watching BLS Pharmaceuticals (ASX:BLS) Shares After Its Latest Price Move - Kalkine

Thu, 06 Aug 2026 02:36:00 GMTMayne Pharma (ASX:MYX) Faces Board Pressure as Investors Push for Strategic Reset After Takeover Collapse - Kalkine

Wed, 05 Aug 2026 07:16:57 GMTMayne Pharma Group Announces Expiry of 24,860 Performance Rights Effective July 30, 2026 - Kalkine Media

Wed, 05 Aug 2026 07:16:57 GMTMayne Pharma Group Issues 161,465 Ordinary Shares Following Performance Rights Conversion - Kalkine

Wed, 05 Aug 2026 07:16:57 GMTMayne Pharma Group Reports Lapse of 24,860 Performance Rights - Kalkine

Related explainers

HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.

Connected entities

ASX12 live mentions MYX8 live mentions Kalkine Kalkine5 live mentions Latest Price Move4 live mentions Kalkine3 live mentions Mayne Pharma3 live mentions Mayne Pharma Group3 live mentions What Healthcare Investors2 live mentions BLS2 live mentions Shares After Its2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Kalkine Mayne Pharma.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

2 distinct publisher/source names are currently connected to this entity page.